TARA – protara therapeutics, inc. (US:NASDAQ)
Stock Stats
News
UK NICE backs Exact's Oncotype cancer genomic test Fri, May 10, 2024, 3:22 PM GMT+2 2 min read 0 In this article: Advertisement Up next These 2 ‘Strong Buy' Penny Stocks Could Surge Over 400%, Says Oppenheimer Thu, May 9, 2024, 7:20 PM GMT+2 6 min read
Protara Therapeutics, Inc. (NASDAQ: TARA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
Protara Therapeutics, Inc. (NASDAQ: TARA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $26.00 to $30.00. They now have an "outperform" rating on the stock.
Here's Why Protara Therapeutics (TARA) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]
Form EFFECT Protara Therapeutics,
Form 424B3 Protara Therapeutics,
Form S-3 Protara Therapeutics,
Form 10-Q Protara Therapeutics, For: Mar 31
Form 8-K Protara Therapeutics, For: May 02
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.